• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 19
      Internships - Criteria and Instructions - 5 month(s) ago

      Acceptance FormA signed and completed acceptance form must be returned to AES by the date indicated in your grant notification letter. Grant payments will be transferred electronically (preferred) or mailed to your institution at the address indicated on the acceptance form. Please complete and return the payment acceptance form in full. No funds can be paid until the acceptance form is completed…

      Source: aesnet.org
      Categories: General Medicine News, Neurology
      Tweet Tweets with this article
      • Profile photo of 	AmEpilepsySoc
        AmEpilepsySoc

        Huge congratulations to Ariana Crary, AES intern at @Manisha44510419's lab ... she was accepted to the CU #Neuroscience program! Bravo! 👏 Learn more about our summer internship grant here: https://t.co/MfystuME5x https://t.co/EQqkMwTahB

    • Mashup Score: 3
      Impact of aging on small molecule transport across the blood-brain barrier in neurodegenerative disorders - 7 month(s) ago

      Neurodegenerative diseases (NDDs) such as Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), Alzheimer’s Disease (AD), Parkinson’s Disease (PD), and Huntington Disease (HD) are projected to become the second leading cause of death by 2040, according to the World Health Organization (WHO). Despite the availability of conventional treatments like medications, therapies, and lifestyle adjustments, these interventions primarily manage symptoms rather than halt or reverse disease progression. Recent research has focused on developing therapies that can modify the underlying degenerative processes. A significant challenge in treating NDDs is the blood-brain barrier (BBB), a dynamic interface that protects the brain but also obstructs drug delivery. Traditional treatment options have largely been unsuccessful, with 190 investigational new drugs failing in clinical trials. The development of non-invasive drug delivery systems, particularly those involving small molecules, has

      Source: www.frontiersin.org
      Categories: General Medicine News, Neurology
      Tweet Tweets with this article
      • Profile photo of 	FrontNeurosci
        FrontNeurosci

        Our Research Topic on aging, small molecule transport, and the BBB in neurodegenerative disorders is open for submissions. 🧠 Share your findings with a global scientific audience! #Neuroscience 🗓️Submission deadline: 28th May More info: https://t.co/6IyA2zOhQi https://t.co/yIUspsVjYW

    • Mashup Score: 6
      Mild cognitive impairment and cognitive aging - 7 month(s) ago

      In 2015, dementia affected 50 million people worldwide, and this number is projected to rise to 152 million by 2050 (WHO, 2019). Mild Cognitive Impairment (MCI) is often seen as an intermediate stage between healthy cognitive aging and dementia. Given the growing population affected by dementia, it is crucial to understand the onset of MCI, its progression to dementia, and the interventions that can prevent or slow down neurodegeneration.The goal of this Research Topic is to highlight the latest advancements in the study of MCI and cognitive aging globally, showcasing the high-quality work of internationally recognized researchers. Several critical questions need to be addressed to enhance our understanding of the relationship between MCI and cognitive aging. These include: identifying which cognitive processes are most sensitive to aging and becoming impaired; determining which interventions are effective for preserving cognitive functioning in old age; understanding the importance of

      Source: www.frontiersin.org
      Categories: General Medicine News, Neurology
      Tweet Tweets with this article
      • Profile photo of 	FrontNeurosci
        FrontNeurosci

        Contribute to our collection on mild cognitive impairment and cognitive aging 🧠 Join us in exploring groundbreaking research to better understand cognitive health and aging #Neuroscience 🗓️Register your interest ➡️Submit here: https://t.co/5PyZv96hEN https://t.co/JnXiOAM7fu

    • Mashup Score: 9
      New Insights in Neurodegeneration: highlights from the 42nd Annual Meeting of the Australasian Neuroscience Society (Perth, Western Australia) - 7 month(s) ago

      The 42nd Annual Meeting of the Australasian Neuroscience Society (ANS) will be held in Perth, Western Australia between December 2nd-4th 2024. To highlight this event, Frontiers in Neurology and Frontiers in Neuroscience are collaborating with the ANS to spotlight important themes from the conference in two Research Topics: ‘New Insights in Neuroimaging’ in Frontiers in Neurology, and ‘New Insights in Neurodegeneration’ in Frontiers in Neuroscience.Research into neurodegenerative diseases has come a long way in terms of underlying mechanisms, biomarkers, and potential treatments. Specifically, recent advances in fluid and imaging biomarkers for Alzheimer’s disease and the treatments that are already on the market or are under investigation are promising. These recent advances, however, require further scrutiny to identify and clarify their shortcomings and propose new approaches and methods that can be close to ideal in terms of accessibility, time and cost-effectiveness, and side effe

      Source: www.frontiersin.org
      Categories: General Medicine News, Neurology
      Tweet Tweets with this article
      • Profile photo of 	FrontNeurosci
        FrontNeurosci

        Frontiers in #Neuroscience proudly presents a new Research Topic in partnership with the ANS 42nd Annual Scientific Meeting, taking place in Perth on 2-4 December! Check the project homepage➡️https://t.co/vsn27voIBZ and don't miss out on the events🗓️ https://t.co/xAgrsQrNTO https://t.co/eaqrfsrKvK

    • Mashup Score: 24
      Large language models surpass human experts in predicting neuroscience results - 7 month(s) ago

      Nature Human Behaviour – Large language models (LLMs) can synthesize vast amounts of information. Luo et al. show that LLMs—especially BrainGPT, an LLM the authors tuned on the neuroscience…

      Source: www.nature.com
      Categories: General Medicine News, General HCPs
      Tweet Tweets with this article
      • Profile photo of 	medical_xpress
        medical_xpress

        AI models outperform human experts in predicting #neuroscience study results, achieving 81% accuracy. This research highlights AI's potential to transform experimental design across scientific disciplines. @uclnews @NatureHumBehav https://t.co/fH3UXTbA0i https://t.co/WcJOIjWpAS

    • Mashup Score: 2
      Dorsal, ventral, and posterior subregions of the striatum: parallel, integrating, or competing functions - 8 month(s) ago

      The cortico-basal ganglia loop is generally thought to be organized into a parallel loop architecture, with segregated circuits subserving limbic, cognitive, motor, and sensory processing spatially separated across subregions of the striatum; the main input nucleus of the basal ganglia. Traditionally, investigators tend to focus on only one of these regions, identifying some functional role of just one subregion at a time in controlling behavior. As such, a widely held dogma has occurred, whereby the ventral striatum (or nucleus accumbens) is implicated in regulating motivation, hunger/satiety, and reward-related to drugs of abuse, with subregions of the core and shell having debatable separate roles. Conversely, the dorsal striatum is generally studied in relation to motor learning and action, albeit with its own subregions of dorsomedial, dorsolateral, and posterior that relate to cognitive, motor, and sensory, respectively.Recently, new evidence has cast doubt on the segregated natu

      Source: www.frontiersin.org
      Categories: General Medicine News, Neurology
      Tweet Tweets with this article
      • Profile photo of 	FrontNeurosci
        FrontNeurosci

        🧠 Advance research on the dorsal, ventral, & posterior striatum! Share your research in our new article collection & drive innovation in #Neuroscience 🚀 More info 👀: https://t.co/C1r67YVcEK Contribute here 👉 https://t.co/0sXHGUEDSs https://t.co/9cwtlRFlJw

    • Mashup Score: 9
      New Insights in Neurodegeneration: highlights from the 42nd Annual Meeting of the Australasian Neuroscience Society (Perth, Western Australia) - 8 month(s) ago

      The 42nd Annual Meeting of the Australasian Neuroscience Society (ANS) will be held in Perth, Western Australia between December 2nd-4th 2024. To highlight this event, Frontiers in Neurology and Frontiers in Neuroscience are collaborating with the ANS to spotlight important themes from the conference in two Research Topics: ‘New Insights in Neuroimaging’ in Frontiers in Neurology, and ‘New Insights in Neurodegeneration’ in Frontiers in Neuroscience.Research into neurodegenerative diseases has come a long way in terms of underlying mechanisms, biomarkers, and potential treatments. Specifically, recent advances in fluid and imaging biomarkers for Alzheimer’s disease and the treatments that are already on the market or are under investigation are promising. These recent advances, however, require further scrutiny to identify and clarify their shortcomings and propose new approaches and methods that can be close to ideal in terms of accessibility, time and cost-effectiveness, and side effe

      Source: www.frontiersin.org
      Categories: General Medicine News, Neurology
      Tweet Tweets with this article
      • Profile photo of 	FrontNeurosci
        FrontNeurosci

        Frontiers in #Neuroscience proudly presents a new Research Topic in partnership with the ANS 42nd Annual Scientific Meeting, taking place in Perth on 2-4 December! Check the project homepage➡️https://t.co/vsn27voIBZ and don't miss out on the events🗓️ https://t.co/xAgrsQrNTO https://t.co/eaqrfsrKvK

    • Mashup Score: 4
      Enhancing Durability of Bioelectronic Implants: Innovations in Encapsulation Materials and Methods - 8 month(s) ago

      The field of bioelectronic implants has seen significant advancements, particularly in the development of neural implants that can restore motor and sensory functions and address various brain diseases and disorders. These implants, which utilize microelectrode arrays and depth electrodes, have shown great promise in recording and stimulating the nervous system. However, a major challenge remains in ensuring their long-term functionality in vivo. Over time, these electrodes, whether rigid metallic probes or flexible microelectrodes, often fail due to immune responses, biofouling, fluid absorption from ineffective encapsulation, and mechanical damage. Addressing these longevity barriers is crucial for the successful translation of these technologies from the laboratory to clinical settings. Recent studies have highlighted the need for more effective encapsulation materials and methods to enhance the durability and performance of these implants. Despite ongoing research, there is still a

      Source: www.frontiersin.org
      Categories: General Medicine News, Neurology
      Tweet Tweets with this article
      • Profile photo of 	FrontNeurosci
        FrontNeurosci

        📢Enhancing Durability of Bioelectronic Implants: Innovations in Encapsulation Materials and Methods Interested in the field of Encapsulation for implants? Check out our latest topic! Submission deadline🗓️April 30th, 2025 More info 👀 https://t.co/Bx2FKSBCZf #neuroscience… https://t.co/D4APLnTQOt

    • Mashup Score: 252
      Olive Oil Linked to Lower Dementia Mortality Risk - Neuroscience News - 8 month(s) ago

      Olive oil could be a key ingredient in reducing the risk of fatal dementia, suggests a new study.

      Source: neurosciencenews.com
      Categories: General Medicine News, Neurology
      Tweet Tweets with this article
      • Profile photo of 	NeuroscienceNew
        NeuroscienceNew

        A spoonful of olive oil could hold the secret to a healthier brain! New research shows that regular olive oil consumption can lower the risk of fatal dementia by 28%. https://t.co/ZNGXJahpcG #neuroscience https://t.co/slzLRxqM42

    • Mashup Score: 13
      AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline - 8 month(s) ago

      Aliada’s lead compound, ALIA-1758, an anti-pyroglutamate amyloid beta (3pE-Aβ) antibody, is a potential best-in-class therapy for Alzheimer’s disease Acquisition also allows AbbVie to utilize…

      Source: news.abbvie.com
      Categories: General Medicine News, Payer
      Tweet Tweets with this article
      • Profile photo of 	abbvie
        abbvie

        NEWS: We announced the acquisition of @aliadatx in a pivotal move to strengthen our #neuroscience portfolio, with the goal of accelerating the development of novel therapies for neurological disorders like Alzheimer’s disease. Learn more: https://t.co/02kU0nmHxE https://t.co/VgCyNp4FYx

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings